Psychiatric Pharmacists: A Leading Solution to the Behavioral Health Workforce Shortage

Patients living with serious mental illness have complex and growing needs and the behavioral health workforce can't keep pace with the ratcheting demand for services. This issue brief outlines this growing crisis and describes how, similar to the VA model, psychiatric pharmacists can serve as a leading option to expand access to care and assist in filling gaps. Congress must take action to remove barriers to the inclusion of psychiatric pharmacists as outlined in the brief.

Download this issue brief as a PDF to save and print.

References are located at the bottom of this page.

References

  1. Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature Mortality Among Adults With Schizophrenia in the United States. Jama Psychiatry. 2015;72(12):1172-81. DOI: 10.1001/jamapsychiatry.2015.1737. PubMed PMID: 26509694.
  2. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16(2):163- 180. DOI: 10.1002/wps.20420. PubMed PMID: 28498599; PubMed Central PMCID: PMC5428179.
  3. Khasawneh FT, Shankar GS. Minimizing cardiovascular adverse effects of atypical antipsychotic drugs in patients with schizophrenia. Cardiol Res Pract. 2014;2014:273060. DOI: 10.1155/2014/273060. PubMed PMID: 24649390; PubMed Central PMCID: PMC3932258.
  4. North Dakota Insurance Department. North Dakota Legislative Management Healthcare Study https://www.insurance.nd.gov/sites/www/files/documents/Communications/Reports/20210108%20ND%20Legislative%20Management%20Interim%20Healthcare%20Study-FINAL.pdf  Accessed 8.22.23
  5. Watanabe JH, McInnis T, Hirsch JD. Cost of Prescription Drug–Related Morbidity and Mortality. Ann Pharmacother. 2018;52(9):829- 837. DOI: 10.1177/1060028018765159. PubMed PMID: 29577766.
  6. Substance Abuse and Mental Health Services Administration. (2021). Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/ https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf  . Page 44. Accessed 8.22.23
  7. Satiani A, Niedermier J, Satiani B, Svendsen DP. Projected Workforce of Psychiatrists in the United States: A Population Analysis. PS. 2018;69(6):710- 713. DOI: 10.1176/appi.ps.201700344. PubMed PMID: 29540118.
  8. American Psychiatric Association Workforce Development https://www.psychiatry.org/psychiatrists/advocacy/federal-affairs/workforce-development Accessed 8.22.23
  9. The Match National Resident Matching Program. Psychiatry 2023. https://www.nrmp.org/wp-content/uploads/2023/01/Psychiatry-MRS-Report.pdf  Accessed 8.22.23
  10. Cobb CD, Puzantian T, Shuman M. Board-Certified Psychiatric Pharmacists and Their Potential Role in Addressing Behavioral Health Workforce Shortages. Psychiatric Services in Advance 2024. Published online March 27, 2024. https://doi.org/10.1176/appi.ps.20230303
  11. Li L, Cooper HR, Parmentier BL, et al. Integrating Board-Certified Psychiatric Pharmacists in a Certified Community Behavioral Health Clinic. Psychiatr Serv. Published online April 10, 2024. doi: 10.1176/appi.ps.20230521
  12. U.S. Department of Veterans Affairs. Pharmacy Benefits Management  https://www.pbm.va.gov/PBM/CPPO/Clinical_Pharmacy_Practice_Office_ResourcesAndTools.asp accessed 9.12.24
    Clinical Pharmacist Practitioner Role in Mental Health February 2024  ExternalFactSheet_CPPRoleinMentalHealth_508.pdf (va.gov) Accessed 9.12.24